Osteonecrosis of the femoral head (ONFH) is a pathological condition, frequently occurring, characterized by cellular necrosis of the femoral head leading to its collapse and hip joint destruction. The pathogenesis is still unclear but several risk factors are involved in the development and progression of ONFH such as trauma, chronic use of corticosteroids, alcohol consumption, coagulation disorders and others.
The Rigenera Technology consists of a minimally invasive procedure. The entire procedure occurs in one surgical time and lasts for about 30 minutes. The whole procedure can be managed in a private practice by a physician, who has received a dedicated training.
In an autologous, homologous and minimally invasive manner where the patient is both donor and acceptor.
The micrografts are obtained starting from small fragments of tissue harvested using a dermal punch, and then mechanically disaggregated with the Rigeneracons medical device. The processed tissue can be then used as a micrograft.
By using Rigenera, the damaged tissue is replaced by the deposition of new tissue making it possible to arrest the degenerative process in the patients.
Fill the form, we will be glad to answer you as soon as possible
Over time, the number of scientific contributions about the applications of the Rigenera Technology to the field of Orthopedics and Rehabilitation has grown. Scientific papers represent a tangible testimony of the practical applications of Rigenera.
You can find out more about our: